Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%
- Johnson & Johnson (JNJ) continues its impressive track record with a 4.2% increase in the quarterly dividend, demonstrating financial stability and commitment to shareholders.
- The 62nd consecutive year of dividend increases showcases Johnson & Johnson's (JNJ) long-term growth strategy and strong financial performance.
- Shareholders can expect a higher annual dividend of $4.96 per share, reflecting the company's consistent growth and value proposition.
- None.
At the new rate, the indicated dividend on an annual basis is
About Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240416660427/en/
Media contact:
Tesia Williams
media-relations@its.jnj.com
Investor contact:
Jessica Moore
investor-relations@its.jnj.com
Source: Johnson & Johnson
FAQ
What is the ticker symbol for Johnson & Johnson?
How much is the quarterly dividend increase announced by Johnson & Johnson?
When is the next quarterly dividend payable to Johnson & Johnson shareholders?
What is the indicated annual dividend per share after the increase announced by Johnson & Johnson?